Barclays’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History
Bought
Maintained
Sold
Other funds holding DTRT
MC
OCAM
PAMP
BFM
CAC
LP
SC
PC
Barclays's DTRT Position: Q4 2022 in Review
Barclays sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q4 2022, closing a stake of 521,762 shares — an estimated $5.3M sold.
Barclays first reported a position in DTRT in Q1 2022 and held it in 3 quarters. The position peaked at $5.3M in Q3 2022. 17 funds tracked by Wall St. Rank hold DTRT as of Q4 2022.
- Barclays reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
- Barclays sold 521,762 DTRT Health Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $5.3M.
- Barclays first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
- Barclays's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $5.3M in Q3 2022.
- 17 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q4 2022.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.